BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 3 hits Enz. Inhib. hit(s) with Target = 'Histone deacetylase 1' and Ligand = 'BDBM411342'   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411342
PNG
(US10385031, Compound 048 | US10774056, Compound 04...)
Show SMILES CN1CCN(CC1)c1ncc(s1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C21H23N5OS/c1-25-9-11-26(12-10-25)21-23-14-19(28-21)20(27)24-18-13-16(7-8-17(18)22)15-5-3-2-4-6-15/h2-8,13-14H,9-12,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, LLC

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10385031 (2019)


BindingDB Entry DOI: 10.7270/Q28P62WR
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411342
PNG
(US10385031, Compound 048 | US10774056, Compound 04...)
Show SMILES CN1CCN(CC1)c1ncc(s1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C21H23N5OS/c1-25-9-11-26(12-10-25)21-23-14-19(28-21)20(27)24-18-13-16(7-8-17(18)22)15-5-3-2-4-6-15/h2-8,13-14H,9-12,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a


TBA

Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


Citation and Details

BindingDB Entry DOI: 10.7270/Q2XD15H9
More data for this
Ligand-Target Pair
Histone deacetylase 1


(Homo sapiens (Human))
BDBM411342
PNG
(US10385031, Compound 048 | US10774056, Compound 04...)
Show SMILES CN1CCN(CC1)c1ncc(s1)C(=O)Nc1cc(ccc1N)-c1ccccc1
Show InChI InChI=1S/C21H23N5OS/c1-25-9-11-26(12-10-25)21-23-14-19(28-21)20(27)24-18-13-16(7-8-17(18)22)15-5-3-2-4-6-15/h2-8,13-14H,9-12,22H2,1H3,(H,24,27)
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a<10n/an/an/an/an/an/a



REGENACY PHARMACEUTICALS, INC.

US Patent


Assay Description
Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten-point three-fold dilution series was made. The compounds were...


US Patent US10774056 (2020)


BindingDB Entry DOI: 10.7270/Q25D8VXS
More data for this
Ligand-Target Pair